Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1

Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1

VG2025 is a recombinant oncolytic herpes simplex virus type 1 (HSV-1) that uses transcriptional and translational dual regulation (TTDR) of critical viral genes to enhance virus safety and promote tumor-specific virus replication without reducing virulence. The TTDR platform is based on transcriptio...

Full description

Bibliographic Details
Main Authors:	Dmitry V. Chouljenko, Yanal M. Murad, I-Fang Lee, Zahid Delwar, Jun Ding, Guoyu Liu, Xiaohu Liu, Xuexian Bu, Yi Sun, Ismael Samudio, William Wei-Guo Jia
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Molecular Therapy: Oncolytics
Subjects:	immunotherapy oncolytic virus HSV-1 cancer vaccine virotherapy microRNA
Online Access:	http://www.sciencedirect.com/science/article/pii/S2372770523000116

Similar Items

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
by: Norah Aldrak, et al.
Published: (2021-06-01)

Cytotoxic effect of dual fluorescent-labeled oncolytic herpes simplex virus type 1 on mouse tumorigenic cell lines
by: Shahriyar Abdoli, et al.
Published: (2019-01-01)

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
by: Takuma Suzuki, et al.
Published: (2021-09-01)

Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study
by: Ravi N. Samy, et al.
Published: (2019-10-01)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
by: Elizabeth Robilotti, et al.
Published: (2023-09-01)

Human Monocytes Are Suitable Carriers for the Delivery of Oncolytic Herpes Simplex Virus Type 1 In Vitro and in a Chicken Embryo Chorioallantoic Membrane Model of Cancer
by: Alberto Reale, et al.
Published: (2023-05-01)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
by: Yoshiaki Yura
Published: (2017-05-01)

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability
by: Edward M. Kennedy, et al.
Published: (2020-09-01)

Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus
by: Jun Ding, et al.
Published: (2022-10-01)

Proteomic Analysis of Secretomes of Oncolytic Herpes Simplex Virus-Infected Squamous Cell Carcinoma Cells
by: Shinya Tada, et al.
Published: (2018-01-01)

Perspectives on immunotherapy via oncolytic viruses
by: Alberto Reale, et al.
Published: (2019-02-01)

Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers
by: Hayle Scanlan, et al.
Published: (2022-07-01)

Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells
by: Zahid Delwar, et al.
Published: (2023-12-01)

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
by: Irene Appolloni, et al.
Published: (2021-08-01)

Entry of Oncolytic Herpes Simplex Virus into Human Squamous Cell Carcinoma Cells by Ultrasound
by: Shusuke Okunaga, et al.
Published: (2015-10-01)

Oncolytic viruses for the treatment of malignant glioma
by: Hong⁃yu LIU, et al.
Published: (2020-02-01)

Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
by: Laura Menotti, et al.
Published: (2020-11-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
by: Ifeanyi Kingsley Uche, et al.
Published: (2021-06-01)

Oncolytic Adenoviruses in Cancer Treatment
by: Ramon Alemany
Published: (2014-02-01)

The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro-tumor genes VEGF and PDL1 expression in the 4T1/Balb/c mouse model of stage four breast cancer
by: Rafiq Nabi, et al.
Published: (2023-06-01)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
by: Jie Yin, et al.
Published: (2017-06-01)

A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
by: Iwai Soichi, et al.
Published: (2011-06-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01)

Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01)

Induction of Durable Antitumor Response by a Novel Oncolytic Herpesvirus Expressing Multiple Immunomodulatory Transgenes
by: Dmitry V. Chouljenko, et al.
Published: (2020-11-01)

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
by: Kimia Kardani, et al.
Published: (2023-05-01)

To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
by: Kevin A. Cassady, et al.
Published: (2016-02-01)

Oncolytic paramyxoviruses-induced autophagy; a prudent weapon for cancer therapy
by: Mohsen Keshavarz, et al.
Published: (2019-06-01)

Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
by: Xiao-Qin Liu, et al.
Published: (2018-01-01)

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma
by: Valentina Marchica, et al.
Published: (2021-02-01)

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
by: Joshua D. Bernstock, et al.
Published: (2021-06-01)

The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1
by: Kiira Kalke, et al.
Published: (2022-06-01)

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
by: Mason J. Webb, et al.
Published: (2023-05-01)

Oncolytic viruses as anticancer vaccines
by: Norman eWoller, et al.
Published: (2014-07-01)

A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition
by: Joshua D. Bernstock, et al.
Published: (2019-12-01)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
by: Jayeeta Ghose, et al.
Published: (2021-03-01)

The Continued Promise and Many Disappointments of Oncolytic Virotherapy in Gastrointestinal Malignancies
by: Daniel H. Ahn, et al.
Published: (2017-03-01)

Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
by: Simona Ruxandra Volovat, et al.
Published: (2024-01-01)

Delivery and Biosafety of Oncolytic Virotherapy
by: Lizhi Li, et al.
Published: (2020-04-01)